ArticleFrontiers in oncology2022

Clinical implications of immune checkpoint markers and immune infiltrates in patients with thymic neuroendocrine neoplasms.

Man Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.